ARCHIVES

MEPACT Approved In Europe For Resectable Osteosarcoma

This article is from The Cancer Letter archive.

Vol. 32 No. 3 | March 27, 2009

Download PDF Visit The Full Archive

Related Articles

Three Experimental Beamlines To Be Built For Research.

May 17, 2002

Rauscher Mammography Guidelines Would Limit Annual Use To Members Of High Risk Group

August 13, 1976

Gleevec Better Than Interferon For Newly Diagnosed CML

May 31, 2002

ORI Must Release Documents In Fisher Case, Judge Rules

September 8, 1995

Myriad In Partnership To Market Products.

December 14, 2001

Government Remains open Under Budget Agreement; New Deadlines Are Oct. 5 & 19

October 5, 1990